Friday , April 26 2024
Home / The Angry Bear / Yes, externalities are real – we’re all paying for Ivermectin

Yes, externalities are real – we’re all paying for Ivermectin

Summary:
Some libertarians oppose vaccine mandates by claiming that unvaccinated people only impose costs on themselves. However, as I noted in an earlier post, we’re all paying for the vaccine hesitancy stirred up on the right. From JAMA (footnotes omitted): Findings suggest that insurers heavily subsidized the costs of ivermectin prescriptions for COVID-19, even though economic theory holds that insurers should not cover ineffective care. Wasteful insurer spending on these prescriptions, estimated at .5 million in the week of August 13, 2021, would extrapolate to 9.7 million annually. For perspective, this total exceeds estimated annual Medicare spending on unnecessary imaging for low back pain, a low-value service that has received extensive

Topics:
Eric Kramer considers the following as important:

This could be interesting, too:

Joel Eissenberg writes Credit where credit is due

Bill Haskell writes Trump’s election interference trial in Manhattan

Angry Bear writes More on Reproductive Freedom…and Polling

Angry Bear writes Sovereign citizens

Some libertarians oppose vaccine mandates by claiming that unvaccinated people only impose costs on themselves. However, as I noted in an earlier post, we’re all paying for the vaccine hesitancy stirred up on the right.

From JAMA (footnotes omitted):

Findings suggest that insurers heavily subsidized the costs of ivermectin prescriptions for COVID-19, even though economic theory holds that insurers should not cover ineffective care. Wasteful insurer spending on these prescriptions, estimated at $2.5 million in the week of August 13, 2021, would extrapolate to $129.7 million annually. For perspective, this total exceeds estimated annual Medicare spending on unnecessary imaging for low back pain, a low-value service that has received extensive attention. The true amount of waste is even higher because estimates did not include Medicaid spending. Moreover, by reducing barriers to a drug that some individuals use as a substitute for COVID-19 vaccination or other evidence-based care, insurance coverage could increase spending for COVID-19 complications.

Leave a Reply

Your email address will not be published. Required fields are marked *